Events and Presentations

Past Events
KBC Virtual Life Sciences Conference

Sep 22 - 23 September 2020

Kiadis will be presenting on Tuesday, September 22, 2020 at 9:00 CET and participating in one-on-one meetings with investors on September 22 and 23.

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

21 September 2020 at 11:40 AM EDT

Click Here for Webcast
Virtual European Biotech Investor Day 2020

25 June 2020 at 1:30 PM EDT

Click Here for Webcast
Annual General Meeting

25 June 2020

Kiadis Pharma will hold its Annual General Meeting ("AGM") of shareholders at Thursday 10:00 CEST on 25 June 2020.

Amsterdam, The Netherlands
2020 Jefferies Virtual Healthcare Conference

3 June 2020 at 11:00 AM EDT

Click Here for Webcast
ISCT Annual Meeting

28 May 2020

ASGCT virtual annual meeting

12 May 2020

Kiadis Pharma 2019 Annual Results

30 April 2020 at 12:00 PM EDT

Click Here for Webcast
BioCapital Europe 2020 - Postponed from March 2020 to Later in the Year

12 March 2020 at 6:10 AM EDT

Amsterdam
Piper Jaffray 31st Annual Healthcare Conference

3 December 2019

Amsterdam, The Netherlands
Jefferies 2019 London Healthcare Conference

20 November 2019

Stifel 2019 Healthcare Conference

19 November 2019

Solebury Trout KOL Day

15 November 2019 at 9:30 AM EST

Arthur Lahr, Chief Executive Officer, will begin with a brief corporate overview which will be followed by a presentation from Dean Lee, MD, PhD – Hematology and Oncology at Nationwide Children’s Hospital and Director of the Cellular Therapy and Cancer Immunology Program at Nationwide Children’s Hospital, The Ohio State U Comprehensive Cancer Center.

 

Click here for Webcast
New York, US
Annual General Meeting

24 June 2019

Kiadis Pharma will hold its Annual General Meeting (“AGM”) of shareholders at 10:00 (CEST) on Monday 24 June 2019 at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.

Amsterdam, The Netherlands
Extraordinary General Meeting of shareholders

28 May 2019

Kiadis Pharma N.V. has convened an extraordinary general meeting of shareholders (“EGM”) to obtain shareholder approval pursuant to section 2:107a of the Dutch Civil Code for the proposed acquisition of CytoSen Therapeutics, Inc. that was announced earlier today. The EGM is to be held on Wednesday, May 29, 2019 at 10:00am CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands. On the registration date (registratiedatum) for the EGM, Kiadis Pharma N.V. had 24,345,076 shares issued, each representing one vote.

Amsterdam, The Netherlands
Extraordinary General Meeting of shareholders

29 March 2019

Kiadis Pharma N.V. has convened an extraordinary general meeting of shareholders (“EGM”) to be held on Friday 29 March 2019 at 10:00 CET at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.

Amsterdam, The Netherlands
Annual General Meeting

4 June 2018

Kiadis Pharma held its Annual General Meeting (AGM) of Shareholders on Monday 4 June 2018 at 10:00 CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.

Amsterdam, The Netherlands